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ENGLISH SUMMARY 
More men than women have a hearing loss, and the incidence of hearing loss increases 
with age. In a study from 2010, the Knowledge Center for Hearing Disabilities 
estimated that 800,000 Danes have disabling hearing loss. The population projection 
from Statistics Denmark (2018) shows that the Danish population is expected to grow, 
primarily due to a growth of the oldest portion of the population. This will result in 
more people in need of treatment for hearing loss in the future. The hearing threshold 
is the clinical measure most often used to determine whether there is hearing loss and, 
if so, how severe. This is measured by tone audiometry which tests how intense a 
given tone must be presented before it can be heard by the patient. Hearing loss can 
also manifest in the form of difficulty understanding and distinguishing words from 
one another. This is typically measured by speech audiometry in which a number of 
words are played and must be repeated by the patient. 
The most frequent treatment for hearing loss is the fitting of hearing aids. The majority 
of treated patients benefit from the use of hearing aids. A hearing aid works by 
receiving and amplifying sound before sending the amplified sound signal to the ear. 
Described as such it may seem simple, yet both hearing and sound processing are 
complex tasks, and there still remains conditions that make successful hearing aid 
treatment a challenge to obtain across the hearing impaired population. More 
knowledge about what characterises these patients, who face challenges, as well as 
knowledge on those who do not, may form the basis of improved treatment in the 
future. 
This dissertation is based on three articles which are based on the first clinical part of 
the Better hEAring Rehabilitation project (BEAR). BEAR is a five-year project whose 
goal is to improve hearing aid treatment in Denmark based on clinical research, and 
if favourable, evidence-based renewal of clinical practice. In the first part of the 
BEAR project, a database containing information on almost 2,000 patients was 
established. Patients were included over the course of a year when examined and 
treated for hearing loss at the Department of Audiology at Odense and Aalborg 
University Hospitals. The database contains data from questionnaires and audiometric 
data, as well as data from an objective measurement of the amplified sound delivered 
to each patient via HAs. 
Manuscript 1 reports on quality of life improvements for first-time and experienced 
hearing aid users after two months of hearing aid use. It was shown that experienced 
hearing aid users had lower hearing-related quality of life compared to new users 
before renewing/fitting new hearing aids. Both groups achieved improvement in their 
hearing-related quality of life after two months of treatment. The overall quality of 
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life score increased for the group of first-time users, whereas no change was observed 
for the experienced users. 
Manuscript 2 reports on quality of life and speech understanding in patients with 
asymmetrical hearing loss, that is, a difference in hearing between the right and left 
ear, compared to patients with symmetrical hearing loss. There is no common standard 
for defining asymmetrical hearing loss and we therefore used three different 
definitions: 1) more than 15 dB interlateral difference in pure-tone average (PTA) 
over four frequencies, 2) more than 15% interlateral difference in word recognition 
score (WRS) and 3) interlateral difference in audiogram configuration. It was shown 
that no matter the definition of asymmetrical hearing loss, patients had poorer hearing-
related quality of life and spatial hearing before treatment compared to patients with 
symmetric hearing loss. Two months of hearing aid treatment improved both groups’ 
hearing-related quality of life and speech comprehension, regardless of asymmetry 
definition.  
Manuscript 3 reports on a study of quality of life changes compared to how the hearing 
aid is fitted, according to the individual patient’s hearing loss. The hearing aid 
amplification in each patient was measured with real ear measurements and compared 
to a curve expected from a standard prescription, targeted to provide optimal speech 
understanding. The amplification provided by the hearing aids when a speech signal 
was played from a loudspeaker was measured and compared to the target curve 
projected by the standard prescription. It was shown that there was no correlation 
between self-reported quality of life, and self-reported hearing handicap in relation to 
the measured gain curve being on or not on reference.  
Overall, it was found that hearing aid treatment significantly improved patients' 
hearing-related quality of life. However, some subgroups of patients achieved less 
improvement than others. Among others, it was shown that patients with asymmetrical 
hearing had lower self-reported hearing-related quality of life and self-reported 
hearing handicap than patients with symmetrical hearing. These results will hopefully 
inspire further research in the field working towards improving health-related quality 
of life through improved hearing care and rehabilitation.
 
9 
DANSK RESUME 
Flere mænd end kvinder har et høretab, og forekomsten af høretab stiger med alderen. 
Videnscenter for Hørehandicap estimerede i en rapport fra 2010, at 800.000 danskere 
har et høretab. Danmarks Statistiks befolkningsfremskrivning fra 2018 viser, at den 
danske befolkningen forventes at vokse, og at det primært er den ældste del af 
befolkningen, der bliver flere af. Dette vil resultere i, at stadigt flere vil have behov 
for behandling for et høretab. Høretærsklen er det kliniske mål der oftest bruges til at 
måle om der er et høretab og i givet fald hvor stort. Den måles ved en tone-audiometri, 
som udtrykker hvor kraftig en given tone skal afspilles, før den kan høres. Høretabet 
kan også vise sig i form af besvær med at forstå og skelne ord fra hinanden og måles 
ved en taleaudiometri, hvor en række ord afspilles og skal gentages af patienten.   
Den hyppigste behandling af en hørenedsættelse sker med høreapparater og langt de 
fleste, som behandles, har god nytte ved brugen af dem. Et høreapparat virker ved at 
opfange og forstærke lyden fra omgivelserne for derefter at sende det forstærkede 
lydsignal ind i øret. Det kan virke simpelt, som det er beskrevet her, men både 
hørelsen og lydprocessering er komplekse systemer, og der er stadigt forhold som gør 
høreapparatbehandling svær at vænne sig til for nogle patienter. Mere viden om hvad 
der karakteriser både de patienter, som har udfordringer og de patienter, som har god 
effekt af høreapparatbehandlingen, skal danne grundlag for endnu bedre behandling 
i fremtiden.   
Afhandlingen er baseret på den første kliniske del af BEAR (Better hEAring 
Rehabilitation) projektet. BEAR er et 5-årigt projekt, hvis mål er at forbedre 
høreapparatbehandlingen i Danmark på baggrund af evidensbaseret klinisk forskning 
og fornyelse af klinisk praksis. I den første del af BEAR projektet blev der etableret 
en database med information om knap 2000 patienter som igennem et år blev 
undersøgt og behandlet på Audiologisk Afdeling på Odense og Aalborg 
Universitetshospital. Databasen består af spørgeskema- og audiometri data, samt data 
fra en objektive måling af hver enkelt patients høreapparatforstærkning af et 
talesignal. Forstærkningen blev målt i patientens øre med den enkelte patients 
høreapparat isat. 
Manuskript 1 omhandler livskvalitetsforbedringer ved nye og erfarne 
høreapparatbrugere efter to måneders brug af høreapparater. Det blev vist, at erfarne 
høreapparatbrugere havde lavere hørerelateret livskvalitet før fornyelse af deres 
høreapparater sammenlignet med nye brugere før behandling. Begge grupper 
opnåede forbedring af deres hørerelaterede livskvalitet efter to måneders behandling. 
Den samlede livskvalitet score steg for gruppen af nye brugere, hvorimod der ikke 
blev set en signifikant ændring for den erfarne gruppe.  
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Manuskript 2 omhandler livskvalitet og taleforståelse hos patienter med asymmetrisk 
høretab, altså forskellige høretab på hhv. højre og venstre øre, sammenlignet med 
patienter med symmetrisk høretab. Der findes ikke en universel standard for hvordan 
asymmetrisk hørelse defineres og vi anvendte derfor tre forskellige metoder til 
definere asymmetri mellem venstre og højre øre: 1) forskel på >15dB i ren-tone-
gennemsnittet (PTA) på fire frekvenser, 2) >15% forskel i ord-genkendelse (WRS) 
og 3) forskel i konfiguration af hørekurve. Det blev vist, at uanset hvordan vi 
definerede asymmetrisk hørelse havde patienterne dårligere høre-relateret 
livskvalitet sammenlignet med patienter med symmetriske høretab. De havde 
ligeledes dårligere rum- og retningshørelse. To måneders høreapparatbehandling 
forbedrede begge gruppers høre-relaterede livskvalitet og taleforståelse uanset 
definitionen for asymmetri.  
Manuskript 3 omhandler en undersøgelse af livskvalitets ændringer sammenholdt 
med hvordan høreapparatet er tilpasset den enkeltes høretab i forhold til et standard 
tilpasningsrationale. Høreapparatets forstærkning, af et afspillet talesignal blev målt 
i hver enkelt patients øre og sammenlignet med den forstærkning, der ifølge et 
valideret rationale blev fremskrevet, at patienten havde behov for, for at opnå bedst 
mulig taleforståelse. Det blev vist at der ikke var en sammenhæng imellem 
livskvalitet og om høreapparatets forstærknings indstillinger var tæt på eller længere 
væk fra en standards forstærkningskurve.  
Overordnet blev det vist at høreapparatbehandling af høretab forbedrede patienternes 
hørerelaterede livskvalitet. Dog opnår nogle patienter større forbedring end andre. 
Det blev blandet andet vist at patienter med asymmetrisk hørelse havde lavere høre-
relateret livskvalitet og taleforståelse end patienter med symmetrisk hørelse. På trods 
af en generel forbedring af høre-relateret livskvalitet og taleforståelse af hele 
studiepopulationen er der stadig patienter, der opnår mindre udbytte end andre. 
Forhåbentlig kan disse resultater inspirere yderlig forskning inden for området for 
fortsat at arbejde mod en bedre høreapparatbehandling. 
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CHAPTER 1. INTRODUCTION   
The WHO estimates (2008) that 5.3% of the world population have a disabling hearing 
loss (HL). In Europe 30% of men and 20% of women present a slight to severe HL 
beyond 70 years of age. This proportion grows to 55% of men and 45% of women 
beyond 80 years of age (Gates and Mills, 2005). Globally, it makes adult-onset HL 
the 15th leading cause of disease and the second leading cause of years lived with a 
disability (WHO, 2017). 
The percentage of the Danish population affected by a HL is not known as no national 
clinical database exist. The latest report on HL in Denmark is from 2006 and it was 
then estimated that 800.000 Danes had disabling HL (Christensen, 2006; Bengtsson 
and Røgeskov, 2010). Higher life expectancy is one of the reasons for the continued 
growth of the general population. As a result, the proportion of the population with 
disabling HL is also bound to increase.  
Being able to hear and communicate is an import aspect of human life, thus for 
patients experiencing HL the consequences can be extensive. The ability to 
communicate is often unaffected in the early onset of HL as the decline in hearing 
may develop slowly and listening strategies may be obtained unnoticeably. Over time, 
HL progresses and can cause exhaustion from trying to hear speech in difficult 
listening environments. As a consequence of not being able to take an active part in 
conversations at social gatherings, HL has a high risk of having a negative impact on 
social interaction (e.g., isolation) and mental health (e.g., anxiety and depression) 
(Dalton et al., 2003; Ishine, Okumiya and Matsubayashi, 2007). 
There is a subtle difference between having a hearing impairment (HI) and 
experiencing HL. The term HI entails having hearing which is different from what is 
understood to be normal hearing regardless of point in time, where the HI arose. The 
term HL, on the other hand, implies that normal hearing was initially present, in order 
to be able to experience a loss. The reason for distinguishing between the two is the 
fact that losing one’s hearing has greater consequences on, for example, social 
interactions then having an innate HI or prelingual HI (Fellinger et al., 2005). Hence 
the term HL is the most appropriate to use in this dissertation.
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CHAPTER 2. BACKGROUND  
2.1. THE BETTER HEARING REHABILITATION PROJECT 
The Better hEAring Rehabilitation (BEAR) project is a five-year project that started 
in the beginning of 2016 as a collaboration between partners engaged in different areas 
of the Danish HA field. The partners involved in the project included three university 
hospitals, three universities, three Danish HA manufactures and a Danish 
government-approved research and technology service.  
Through this unique collaboration of partners, the probability of the results being 
directly beneficial to the patients is highly likely. The field of HA is well studied, but 
there is still potential for more results from the field to be translated into changes and 
improvements to the clinical practise. The aim of the BEAR project is to achieve better 
HA rehabilitation, through studies of the clinical practise related to HA fitting. The 
project is divided in three phases: 1) Clinical database and improved HA-outcome 
assessments, where among others documenting current clinical practices by gathering 
data on HA users, 2) validation of new strategies and proposals of revised standards. 
Apart from the database being used as a reference in the other phases of the project, it 
is also used to study various epidemiological contexts. 
2.2. HEARING LOSS 
The auditory sense is understood as the ability to perceive and decode sound waves 
through the ear canal, the middle ear and the cochlea, and further through the auditory 
vestibular nerve to the superior temporal gyrus of the temporal lobe, where the 
primary auditory cortex lies. A problem in any one of these structures can lead to HL, 
which can present in a variety of forms.  
Clinically, HL can roughly be described in two ways: 1) as the tone threshold and/or 
2) the speech-reception threshold. The tone threshold is an expression of a patient’s 
ability to hear different pure tone frequencies at the lowest possible sound pressure. 
The results of the test are expressed in a pure tone audiogram in dB HL, and does not 
take the patient’s hearing skills or central processing ability into account. The speech-
reception threshold is a measure of the ability to discriminate and understand speech. 
The two ways of measuring HL do not necessarily follow from one other. A patient 
can have an audiogram-determined HL without the coexistence of a discrimination 
disability, and vice versa (Vermiglio et al., 2012). The disagreement between the 
audiogram and the degree of difficulties the patient experience is one of the aspects 
which pose a challenge for hearing rehabilitation. The audiogram has been, and still 
is, used as the “gold standard” for HL. However, the audiogram is a poor indicator of 
speech recognition, especially for speech in noise (Blandy and Lutman, 2005), which 
is the primary complaint of HA users.  
CHAPTER 2. BACKGROUND 
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Going into further details, the audiogram is used to classify HL into three types: 
sensorineural, conductive and mixed HL. The cause of sensorineural HL can be 
present in the inner ear, the cochlea or the related structures. The full explanation of 
what causes the sense of hearing to decline is still unknown, as the interplay between 
the different structures is very complex. Conductive HL is a consequence of more 
mechanical nature and a linear amplification of sound via a HA can in some cases 
alleviate the HL, as the nerve leading the sound input and central processing is 
unaffected. With pronounced conductive HL, surgery or fitting a bone-anchored 
hearing aid can be an alternative if a conventional HA is insufficient. As it is possible 
to have multiple sites of lesions, a mixture of sensorineural and conductive HL is also 
a possibility. The treatment depends on which lesion dominates the HL. A 
combination of surgery and HA treatment might also be a solution.  
The reason for a lesion in the hearing-process can further complicate the matter. The 
lesion can be present at birth or be acquired due to traumas and/or ageing. The most 
prevalent type of HL in adults is acquired sensorineural HL (SNHL), which primarily 
stems from structural decay in the inner ear, the cochlea. SNHL is one of the few 
chronic conditions for which there is no effective medical or surgical treatment. 
However, the HL needs to be acknowledged by the patient before treatment can be 
considered.  
Untreated HL can have widespread consequences for the patient. Even a mild degree 
of HL can cause social, emotional and communication difficulties and thus a reduced 
health-related quality of life (HRQoL). The first choice for hearing rehabilitation is 
often HAs and the derived symptoms of HL can to some extent be alleviated with HA. 
Hearing rehabilitation can result in small but clear improvements in social, emotional, 
communication and cognitive functions (Mulrow et al., 1990). In recent years, HA 
technology has steadily improved, with increased benefits for people with HL (Sorri 
et al., 2001; Kaplan-Neeman et al., 2012). 
2.3. HEARING AID REHABILITATION  
The first choice for HA rehabilitation for patients with SNHL is conventional HAs, 
which deliver amplified sound to the ear canal. The aim of rehabilitation is to reduce 
the impact of HL on the patient’s life (Boothroyd, 2007). The history of HAs goes 
back hundreds of years, from the first ear trumpets in the nineteenth century to the 
digital HAs we use today, and the development of listening devises is still ongoing. 
Various signal processing techniques are used in HAs. When the digital HA was 
introduced, more signal possibilities became available. The HAs fitted today are 
advanced amplifiers which improve the likelihood of the speech signal being 
optimally delivered to the auditory system and prevent intense sounds by 
compression. Although, compression causes distortion, troublesome distortion is no 
longer a significant factor in HA signal processing (Bentler and Duve, 2000). The use 
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of wide-dynamic range compression has provided the opportunity of a uniform access 
to the softest and loudest speech cues (William Yund and Buckles, 1995; Franck et 
al., 1999). The directional microphone has been used to improve the signal-to-noise 
ratio in certain communication settings (Ricketts and Galster, 2008).  
A HA must be fitted according to the specific HL in order to provide maximal benefit 
to the user. The fitting consists of two parts: prescription and fine-tuning. The 
prescription is an algorithm is designed to maximise speech intelligibility by 
providing optimum amplification across frequencies based on the patient’s hearing 
threshold (Mueller, 2005). There are at least two validated and commonly accepted 
prescriptive fitting methods: the National Acoustic Laboratories Non-Linear version 
2 (NAL-NL2) (Keidser et al., 2011), and the Desired Sensation Level version 5 
(DSLv5) (Scollie et al., 2005). While some manufacturers (such as Bernafon, Siemens 
and Unitron) recommend using established prescription procedures such as NAL-
NL1/2 and DSL as a baseline for fitting their devices, others have introduced their 
own proprietary fitting algorithms (such as Oticon, Phonak, GN ReSound and Widex) 
(Keidser, Brew and Peck, 2003). Fitting is often followed by a fine-tuning, which is 
an iterative process based purely on subjective feedback from the user. Based on 
clinical experience, there is a specific challenge regarding first-time users of HA, as 
they tend to trade functionality for a more comfortable amplification level. 
2.4. HEALTH-RELATED QUALITY OF LIFE 
Alongside the development of better treatments and increased healthcare costs, not 
only in audiology care but throughout the medical system, new outcome measures 
have developed. One of the reasons for the development of new outcomes measures 
is due to the continuing rise in healthcare expenses, both in total but also as a 
percentage of gross national product (OECD and European Union, 2018).  
In other fields of human pursuit, e.g. production of food or private services, the 
success is measured by its profit. However, the measure for success of a treatment is 
debatable; and when it comes to comparing different types of treatments, including 
across medical fields, it becomes even more difficult. We do not have to look back 
more than 70 years to find a time, where advanced treatment was unavailable and 
the discussion of whether or not the treatment is worth the cost did not exist. As 
medical science developed, the need for the systematic evaluation of the benefits and 
effectiveness of treatment has emerged. Concurrently, the WHO define health as “a 
state of complete physical, mental and social well-being and not merely the absence 
of disease or infirmity”. 
In the late 1950s there was a shift towards the emphasis of a person’s capacity and 
ability to perform daily activities, well-being and quality of life (QoL). The term 
health-related quality of life (HRQoL) has been introduced to describe the aspects of 
QoL that excludes aspects not related to health, for example cultural, political or 
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societal attributes (Ferrans et al., 2005). HRQoL is a multidimensional concept which 
covers patients’ perceptions of his or her physical, emotional, social and cognitive 
functions. HRQoL emphasises the personal perception of the quality of one’s life 
based on personal expectations. The uniqueness of a person’s own experience of how 
the condition emerges suggests that two people with the same disease can judge their 
HRQoL very differently (Ferrans et al., 2005). 
 
2.4.1. DISEASE-SPECIFIC QUESTIONNAIRES  
Numerous questionnaires exist to measure and document the improvement of HA 
benefits and HRQoL. The questionnaires that focus on a specific illness or 
intervention are referred to as disease-specific measures. They have been developed 
to measure health status in a clinical investigation, for example when evaluating one 
treatment for a disease against an alternative treatment. Several questionnaires address 
the functional HA benefit, satisfaction and HRQoL within a single questionnaire, such 
as the International Outcome Inventory of Hearing Aids (IOI-HA)(Cox and 
Alexander, 2002). Another questionnaire often used in clinical and research-related 
contexts is the short form of Speech, Spatial and Qualities of Hearing Scale (SSQ12) 
(Noble et al., 2013). The difference between the two is the general character of the 
IOI-HA, whereas the SSQ12 examine the hearing disability in greater detail. These 
specific questionnaires have been chosen as tools for the collection of data for the 
BEAR database, as they are widely used in both Danish and international contexts and 
therefore allow for the possibility of comparisons with previous studies. 
The IOI-HA was developed as a supplement rather than a stand-alone instrument with 
the intension to provide directly comparable data on an international level. It has 
become popular in recent decades as it has a low patient and clinician burden, and it 
is easy to interpret. Additionally, it has been designed to minimise literacy and 
cognitive demands, and it is therefore widely applicable (Cox, Alexander and Beyer, 
2003). It consists of seven questions addressing the main dimensions of HA treatment. 
A limitation of the IOI-HA is that it does not provide specific information about 
hearing performance in different listening situations and is therefore used as a 
supplement in this study (Hickson, Clutterbuck and Khan, 2010).  
A questionnaire designed to provide the details missing from the IOI-HA is the 
SSQ12. It comprises 12 questions grouped in three sections and is used to measure 
several aspects of hearing ability, such as speech comprehension in quiet and noisy 
environments, localisation of sound, segregation and listening effort. Each question is 
answered on a scale from 0–10, where 10 means being able to perform perfectly in 
the situation in question. The questionnaire is valid for self-administration methods 
(Singh and Pichora-Fuller, 2010) and has been widely used for assessment in various 
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studies (Noble and Gatehouse, 2004; Dumper et al., 2009; Olsen, Hernvig and 
Nielsen, 2012).  
Being able to compare results within hearing research is one aspect, though in order 
to be able to compare interventions across medical fields, measuring overall health 
status is required. For this purpose the generic HRQoL questionnaires are used. 
2.4.2. GENERIC HRQOL QUESTIONNAIRES 
Most generic questionnaires include items related to the major health domains of 
physical, social and mental health, though they differ in the level of detail which they 
assign these dimensions or of questions pertaining to these domains. The absence of 
hearing-related questions on most commonly used health status questionnaires has 
made it difficult for researchers to ascertain the effect of HAs for adult-onset hearing 
impairment. The most frequently used generic HRQoL questionnaires in hearing 
research include the 36-item Short Form Health Survey (SF-36) (Scoggins and 
Patrick, 2009), the EuroQoL 5-dimensions (EQ-5D) (EuroQoL Group, 1990) and the 
Multi-Attribute Health Status Classification System (HUI-3) (Horsman et al., 2003).  
It is not an essential requirement that a generic questionnaire include a question on 
hearing in order to measure improvements due to interventions directed at HL. 
Nonetheless, when such a question is not included there arises concern whether the 
generic HRQoL questionnaire is sensitive to interventions which improve hearing 
(Summerfield and Barton, 2019). Two of the generic HRQoL questionnaires that do 
not include a question on hearing is the SF-36 and EQ-5D. It is concluded in a review 
of previous HA research that the SF-36 appears to lack responsiveness to the effects 
of interventions for adult onset HL (Bess, 2000) and thus that an alternative should be 
used in the case of hearing research. With regard to the EQ-5D, a study evaluating its 
sensitivity in hearing research concluded that the EQ-5D should be used to evaluate 
interventions intended to improve tinnitus, though it lacked sensitivity to measure 
impaired speech reception (Summerfield and Barton, 2019).  
The HUI3 generic HRQoL questionnaire has been widely used in the USA, the UK, 
Australia and Canada, where it was evolved. The HUI3 has been evaluated in terms 
of its responsiveness to HA interventions and has also been used effectively in 
measuring HRQoL improvements among cochlear implant recipients (Wyatt et al., 
1996; Francis et al., 2002). The HUI3 has been translated into Swedish yet its use in 
the Scandinavian countries is limited and it has not yet been translated into Danish or 
been validated.  
The 15 dimension-instrument (15D) has been translated into Danish and was validated 
through the creation of utility weights based on a subset of the general Danish 
population (Wittrup-Jensen and Pedersen, 2008). Although differences exist, the 
HUI3 and 15D share many similarities. The use of the 15D in hearing research is 
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limited, but it has been shown to have a sensitivity toward hearing-related 
interventions (Niemensivu et al., 2015). 
2.4.3. 15D-INSTRUMENT 
The 15D is a generic HRQoL questionnaire developed in Finland for use in socio-
economic studies to evaluate the cost-benefit of a treatment or intervention. The 15D 
consist of 15 questions/dimensions which have an impact on HRQoL. The 15D 
includes questions on Mobility (move), Vision (see), Hearing (hear), Breathing 
(breath), Sleeping (sleep), Eating (eat), Speech (speech), Excretion (excrete), Usual 
activities (uact), Mental function (mental), Discomfort and symptoms (disco), 
Depression (depr), Distress (distr), Vitality (vital) and Sexual activity (sex). Each 
dimension is answered by the patients selecting one of the five levels that best describe 
his/her present health status. The 15D provides both a profile and total HRQoL score 
based on national utility weights/utility measures. 
Like the HUI3, the 15D assess HRQoL through the use of utility measures. Utility 
measures refer to the preference of an individual or population for a particular health 
state (Bennett and Torrance, 1996). As part of the 15D, the utilities are measured with 
a scale ranging from 0–1, where 0 designates death and 1 designates perfect health. 
This approach makes is possible to compare the effect of disease and interventions on 
HRQoL within and across disorders.  
The utility measures/weights are derived from the validation process, where the 15 
domains are ranked according to their impact on HRQoL, from most to least impact. 
The order of dimensions may vary due to cultural differences across national borders, 
hence national validation and utility scores are recommended, when making use of 
the 15D (Badia et al., 2001; Wittrup-Jensen and Pedersen, 2008). Not only are the 15 
dimensions themselves ranked, but the five levels in each of the dimensions are also 
ranked. The within-dimension ranking is used when forming a profile, whereas both 
the within-dimension and the between-dimension rankings are used, in the total 15D 
score (Wittrup-Jensen and Pedersen, 2008).  
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For example, a person is asked to select one of the five descriptors that best represent 
his or her hearing and hearing related QoL (15D-3, Table 2.1). Each descriptor (1 to 
5) is associated with a different utility weight, for example for 15D-3: 1 = 1.0; 2 = 
0.7734; 3 = 0.5439; 4 = 0.2969 and 5 =0.1621 (Table 2.1). 
 
  
In the analysis of the 15D responses, utilities are measured for the multiple domains 
and a summary measure is calculated to provide an overall score. These utility scores 
allow for an estimation of quality-adjusted life years (QALYs) and the further 
application of these can be used in the estimation of cost-utility ratios for various 
diseases. 
2.4.4. QUALITY-ADJUSTED LIFE YEARS (QALYS) 
With the competing demands for resources across the medical field, the role of 
economic evaluation in healthcare is to provide information on relative costs and 
benefits to support decision makers regarding how to prioritise available resources. A 
particular approach to economic evaluation, cost-utility analysis, has become a key 
analytical tool for health economists. Within cost-utility analysis, benefit from 
treatment is measured in terms of QALYs. The QALY is a metric that combines 
information on both the duration and quality of life following treatment. Since the 
traditional measures of HRQoL, using generic or specific instruments, are of limited 
use in economic evaluations, it is necessary to include a preference-based utility 
measure in order to be able to make these evaluations (Drummond et al., 2015). In the 
past decade a growing number of studies have used these economic evaluations in 
hearing research to document the fact that patients with untreated HL have lower 
HRQoL compared to a standardised population, and that HA treatment can 
significantly improve HRQoL. Hence, justifying the costs involved in the treatment.  
(Lutman, Brown and Coles, 1987; Mulrow et al., 1990; Swan, Guy and Akeroyd, 
2012). 
Table 2.1 Utility weights for the various health states for the hearing dimension (15D-3). The 
utility weights presented are the Danish weights with the English description. The table is 
adapted from the 15-Dimension instrument (www.15d-instrument.net/15d/) and the Danish 
validation of the 15D questionnaire by Wittrup-Jensen and Pedersen (2008).  
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2.5. OBJECTIVE MEASURE 
Determining the benefit of HA treatment, the terms validation and verification are 
often used (Jorgensen, 2016). Validation measures refer to outcome measures 
designed to assess whether the HA is of benefit to the patient, while verification 
measures primarily focus on ways to confirm that the gain from the HA matches the 
prescribed target. Common to both ways of evaluating HA benefits is the aim of 
ensuring the best possible acoustic information for appropriate speech 
communication. Many speech tests have been developed in an attempt to objectively 
measure the effectiveness of HA treatment, for example the word recognition test 
(Causey et al., 1983; Elberling, Ludvigsen and Lyregaard, 1989) and the hearing-in-
noise test (Nilsson, Soli and Sullivan, 1994). However, although these tests provide a 
measure of change in audibility after HA treatment they depend on the patients’ 
subjective response and do not validate whether the amplification of sounds is 
adequate. Further, research has found that these tests lack real-world validity, while 
clinicians found a use of a functional gain measure using various prescriptive 
approaches (Abrahamson et al., 2005). 
2.5.1. REAL EAR MEASUREMENT 
An increasing use of real ear measurement (REM) among audiologist has been 
reported (Aazh and Moore, 2007), as it can be used in the verification of a HA fitting. 
It is an objective measure that ensures that the HA operates appropriately by analysing 
the output of the HA through probe microphone measurements. REM is the valid 
manner in which to verify the actual sound delivery of a particular HA used in a 
particular patient’s ear canal. The use of REM in Denmark is limited and no national 
clinical recommendation or guideline currently exists. In the fast developing HA 
industry of today, the need for verifying HA-amplification seems appropriate, as HA 
fitting with proprietary prescriptions is becoming more common. No recent national 
inventories on the use of prescriptive methods exits, but in the BEAR database 97% 
of the patients had their HAs fitted according to the proprietary fitting. The REM 
method is thoroughly described in the method section of this dissertation. 
2.6. CLINICAL RESULTS OF PREVIOUS STUDIES  
For many decades the interest in developing and documenting the effect of modalities 
for treating HL has been growing. The result is that the amount of instruments used 
to investigate HA benefits is numerous. The coordinating work regarding HRQoL 
research and HA treatment has not yet been successful, although attempts have been 
made (Shield, 2019). In general, the benefits of HAs have been well studied and many 
different instruments have been used. The results obtained are heterogeneous, though 
they provide a clear picture that not only is HA treatment justified but also that 
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untreated HL has extensive individual and socio-economic detrimental consequences 
(Shield, 2019). 
2.6.1. HEARING AID BENEFIT AND HRQOL 
Several studies have evaluated HA outcomes with hearing-specific measures which 
are highly responsive to interventions targeting HL. Most of the studies have shown 
a strong reduction in the emotional and social impacts of HL after HA treatment. In a 
study using the disease-specific questionnaire Hearing Handicap Inventory for Adults 
(HHIA) (Newman et al., 1990) to investigate the outcomes of HA fitting  they found 
a positive impact on HHIA scores three months after HA fitting (Stark and Hickson, 
2004). Furthermore, they found a relationship between the change in HHIA score for 
the participants with HL and two factors: degree of HL and reported use-time of HA. 
Patients with a speech frequency pure-tone average HL (0.5, 1 and 2 kHz) greater than 
35 dB HL reported greater reduction (the lower the HHIA score, the less the disability) 
when compared to the reduction found when the speech frequency PTA HL where 
less than 25 dB HL. The finding directly relates to the fact that those with greater HL 
experience more hearing problems before HA treatment and therefore have a greater 
potential for an improvement after treatment. For the relationship between HHIA 
score and use-time of HA, the improvement was greater for those patients who wore 
their HAs more (Stark and Hickson, 2004). Similar significant improvement was 
found in the emotional and social domains using the same or other disease-specific 
questionnaires (Dalton et al., 2003; Chisolm et al., 2007; Ishine, Okumiya and 
Matsubayashi, 2007). The implication of HL on more than audibility is further 
supported by a study which found an association between HL and social isolation and 
depression (Dawes et al., 2015).  
Research regarding generic HRQoL is varied (Chisolm et al., 2007), but the results 
regarding the reduction of depression or/and anxiety have been reproduced using 
generic HRQoL questionnaires (Mulrow et al., 1990; Joore et al., 2002). Additionally, 
reduction in the subscales of general health and vitality as a result of HA treatment 
have been found (Stark and Hickson, 2004), measured three months after fitting, using 
the Short Form-36 (SF-36) (Ware and Sherbourne, 1992).  
Common to hearing research is the fact that is has been undertaken by studying first-
time users of HAs. One of the few studies that includes experienced HA users (Cox, 
Johnson and Xu, 2014) found improved HRQoL after one month of treatment, though 
they report their findings in the context of advanced HA versus basic HA technology. 
Unfortunately, they do not report separate results for the two groups of HA 
experience. As it is custom in Denmark to renew HAs when the warranty on the HAs 
expires after four years, it is highly relevant to evaluate whether the treatment up to 
the point of HA renewal is optimal. There is a lack of research investigating for how 
long the initial positive impact of HA lasts, as most studies end their observation no 
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within one year after HA fitting. The impact of HA experience on HRQoL is discussed 
in Manuscript 1 in the thesis.  
Other groups of patients known to experience low benefits from HAs are patients with 
bilateral asymmetrical HL (AHL) and patients with unilateral HL (UHL). The 
hypothesis that asymmetrical hearing has a negative consequence on hearing 
performance is well investigated in the literature. However it was not until the mid-
60’s that Giolas and Wark (1967) turned research attention towards the difficulties 
experienced by patients with asymmetrical hearing in complex listening situations. 
They write that “it has become increasingly apparent that a special clinical program 
must be developed to meet the specific needs of a person with unilateral hearing loss”. 
In the years leading up to this research, empirical evidence had made clinicians 
increasingly aware of the problem (Harford and Barry, 1965). Thus, it is now well 
established in the literature that the absence of balanced binaural hearing makes sound 
localisation and speech understanding in noise a challenge for both individuals with 
normal hearing and individuals with HL (Häusler, Colburn and Marr, 1983; Peissig 
and Kollmeier, 1997; Firszt, Reeder and Holden, 2017). Further studies have shown 
that the consequences of having AHL includes the disturbance of communication and 
is associated with increased effort during real-life listening conditions (Wie, Pripp and 
Tvete, 2010; Dwyer, Firszt and Reeder, 2014). The majority of research on the 
significance of asymmetrical hearing include patients with UHL, while fewer studies 
investigating AHL exist. 
A 2004 study (Noble and Gatehouse) examined the effect of AHL, defined as a 
interlateral difference of PTA (0.5, 1, 2 and 4 kHz) more than 10 dB. They found that 
patient with AHL had significantly poorer spatial hearing when self-assessed using 
the SSQ compared to patients with symmetrical HL (SHL). The negative effect of 
AHL/UHL on spatial hearing has been shown in previous clinical studies, although 
often in the context of post-surgery for vestibular schwannoma (Humphriss et al., 
2004; Douglas et al., 2007). Later studies also support this conclusion, as Olsen, 
Hernvig and Nielsen (2012) found that self-reported sound localisation and estimation 
of distance from sources were rated worse when a patient has UHL. The consequences 
of AHL is discussed in Manuscript 2 in this dissertation.  
Based on existing research results, there is little if any doubt that hearing rehabilitation 
with HAs in general is of considerable benefit to patients with HL. There are, 
however, patients who do not experience the positive effects of HA treatment. In 2011, 
it was estimated the 20% of the HAs distributed in Denmark ended up not being used 
(Parving, 2011). It is a rough estimate and the number reported by others varies from 
4.7% (Hougaard and Ruf, 2011) to 24% (Hartley et al., 2010). Many studies have 
examined use time of HAs, including a 2012 systematic review (Perez and Edmonds, 
2012). They found a lack of consistency in the way that use of HAs was assessed and 
categorised. Nonetheless, it is generally well known that there are patients not 
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enjoying the intended benefit from their HAs, though the reasons are to a large extend 
unknown.
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CHAPTER 3. MATERIALS AND 
METHODS 
3.1. PARTICIPANT 
This study included a large number of patients referred for HA treatment at the 
involved clinics. In the Region of Southern Denmark a collaboration with the local 
ENT practitioners was established. Patients were informed of the project and invited 
to participate during their visit to their local ENT. Consent to participate was noted in 
the referral letter to the Department of Audiology, Odense University Hospital (OUH) 
and patients were included in the BEAR database. In the North Denmark Region, 
patients followed the normal flow of referral from private ENT practitioners to the 
Department of Audiology, Aalborg University Hospital (AAUH) (manuscript 1). 
Patients booked as first-time users of HAs were sent a digital invitation to the study 
14 days prior to their hearing examination. Recruitment at both sites started in January 
2017 and the last follow-up was in June 2018. A total of 1961 patients were included.  
Patients were accepted into the study if they met the following criteria:  
 Adults (≥18 years) 
 Had a serviceable hearing loss 
 Were able to read and understand Danish 
  
 Patients were excluded if they:  
 Were candidates for cochlear implants or bone anchored hearing aids  
 Were candidates for other surgical treatments of HL (e.g. otosclerosis)  
 Had malformations of the auricle and/or inner ear 
 Had tinnitus without a concurrent clinical diagnosed HL  
 
Patients made a free and informed choice before consenting to participate and signed 
a written consent form. 
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3.2. THE CLINICAL DATABASE 
All studies in this thesis are based on the data collected as a part of the first clinical 
study of the BEAR project. Based on the time allocated for data collection and power 
calculations, the goal was to recruit 2,000 patients for the database. The database 
should serve as a base for investigating various hypotheses regarding patients with 
HL who received HA treatment. The database is to hold information on general patient 
characteristics and quantitative survey data in combination with audiological data. 
The comprehensive database should make the categorisation of relevant subgroups 
possible. Identifying subgroups experiencing a low benefit of HA and their 
characteristics was of particular interest. For the survey part of the database, a set of 
five international well-known and used questionnaires were agreed upon, alongside 
general health-related questions. The database was built using the browser-based 
Research Electronic Data Capture (REDCap) platform (Harris et al., 2009) hosted at 
OPEN, Region of Southern Denmark. A study record was created using the patients' 
name and civil registration number (CPR number). REDCap allowed us to 
electronically distribute unique links to every patient included in the project via a 
digital mail box (E-boks) and therefore their answers were directly entered into the 
database. Features of the REDCap system managed the distribution of the 
questionnaires based on the patients’ appointments at the clinics.   
The audiometric data was collected using AuditBase, with the audiometry software 
OTOsuite (Otometrics), Titan and Affinity (Interacoustics) and HA fitting software 
(e.g. Genie from Oticon, Compass GPS from Widex and Resound Smart Fit from GN 
ReSound). All software is compatible with the NOAH System, which makes 
integration possible across brands and ensures direct access to audiometric and HA 
fitting data. During data collection the audiometric part of the BEAR database was 
organised into two different modules, as audiometric data was distributed between the 
OUH and AAUH. Close collaboration between the two clinics minimised the 
differences in audiometric procedures. 
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3.3. STUDY TIMELINE 
Patients were referred to OUH or AAUH by their private ENT practitioners for further 
hearing examinations and HA fitting if favourable. Patients were sent a link to the 
baseline questionnaires two weeks prior to their hearing examination (Figure 3.1). 
 
After the first visit, patients were scheduled for HA fitting approximately six weeks 
after the first visit. Before leaving their HA fitting appointment they were booked for 
a subsequent follow-up visit after two months. Two weeks before the follow-up visit, 
follow-up questionnaires were distributed. At the follow-up visit a REM was 
performed before registration of the HA type, model, ear-plug/mould, fitting rationale, 
average use time of HA and program use in REDCap. If the patients expressed a 
dissatisfying physical fit or problems with sound qualities in the HA, adjustments 
were made. In case of adjustments the REM procedure was repeated. 
3.4. MEASURES  
3.4.1. AUDIOMETRY 
An audiometric examination was performed according to current clinical practises and 
was initiated with an otoscopy to secure an open ear canal and the status of the 
tympanic membrane. At the first visit several standard measurements were taken by 
trained audiology assistants; all audiological tests were done using a Madsen Astera 
2 (Type 1066) audiometer, calibrated yearly, and with AC Headset TDH39 
headphones in AAUH and insert earphones ER-3A in OUH. 
Unaided air conduction (AC) audiometry was performed using the ascending method 
(ISO 8253) for both ears with pure tones at standard audiometric frequencies (250, 
500, 750, 1000, 1500, 2000, 3000, 4000, 6000 and 8000 Hz). The 750, 1500 and 6000 
Hz frequencies were tested only when the neighbour octave frequencies provided a 
threshold of more than 20 dB apart (the 20 dB rule). The contralateral ear was masked 
using narrow band noise whenever the BC threshold was ≥35 dB apart. The 
measurement started at 50 dB HL unless a more ideal level was selected based on the 
referral audiogram.  
Figure 3.1 Study timeline 
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Bone conduction (BC) audiometry was performed with a bone stimulator at standard 
audiometric frequencies (500, 1000, 2000, 3000 and 4000 Hz). If the difference 
between AC and BC thresholds were ≤10 dB then the BC thresholds were completed 
unmasked for the best hearing ear and also indicated on the audiogram for the best 
hearing ear. Masking of the contralateral ear was done using narrow band noise 
whenever the difference in threshold between AC and BC was ≥10 dB.  
Unaided speech reception threshold (SRT) was measured separately for each ear using 
headphones in quiet. If indicated by the AC, masking was applied. The first threshold 
reached, where two digits out of a triplet were correctly heard, determined the level 
of the SRT (DANTALE) (Elberling, Ludvigsen and Lyregaard, 1989).  
The unaided word recognition score (WRS) was assessed in quiet for each ear 
(contralateral ear masked when possible) using the DANTALE word test (Elberling, 
Ludvigsen and Lyregaard, 1989) and reported in percent, with 100% signifying that 
all words were correctly repeated. WRS was measured at 30–40 dB above pure tone 
average (PTA; average of hearing sensitivity at 500, 1000 and 2000 Hz), depending 
on the hearing status, but at a minimum of 70 dB HL.  
The DANTALE word test consists of eight lists of 25 phonetically balanced, 
monosyllabic words (lists 1 and 2 are used most often). In cases where the standard 
WRS was 20% or less a detailed S-curve was performed to uncover potential sound 
pressure levels with better WRS.  
At AAUH, wideband tympanometry was performed using Titan Suite IMP440 
Impedance Wide Band module (Interacoustics). Via a probe placed in the patient’s 
ear canal, 21.5 clicks per second were played at an intensity of 100 dB SPL (65 dB: 
normal HL) while the ear canal pressure changed from +250 daPa to –350 daPa with 
a pump speed of 100 daPa/second (1 daPa = 10 Pascal). At OUH, conventional 
tympanometry was performed using standard equipment to estimate compensated 
static admittance and tympanometric width, peak pressure and ear canal volume. A 
probe tone of 226 Hz was presented in the ear canal and admittance was measured 
while air pressure in the ear canal was varied from +200 to –400 daPa. 
Stapedius reflex thresholds were measured with headphones (TDH-39) and 
Interacoustics Titan IMP440 Impedance module with insert earphones at 500, 1000 
and 2000 Hz, starting with contralateral reflexes. Contralateral reflexes were tested at 
80 dB HL and raised until triggered or to a maximum of 110 dB HL. For ipsilateral 
reflexes the sound level started at 80 dB HL and was raised until triggered or to a 
maximum of 100 dB HL. 
3.4.2. QUESTINNAIRES 
In the first part of the general health-related questionnaire, the patients were asked 
about background characteristics (e.g. age, gender, smoking, alcohol, etc.), HA 
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experience, history of occupational or recreational noise exposure, tinnitus and 
motivation for improving their hearing and belief in their ability to use HAs. The 
second part of the health-related questionnaire contained questions on current work 
status, type of occupation, sound environment at work, etc. 
3.4.3. REAL-EAR MEASUREMENTS 
Before initiating the follow-up visits, training, including REM was coordinated 
between the lead investigators at OUH and AAUH, to ensure uniform performance of 
the measurements. Training in the use of the equipment and setting up the protocol 
was made jointly between OUH and AAUH, with the help of senior specialists from 
FORCE Technology, Technical-Audiological Laboratory and a senior scientist at 
Widex. At AAUH, all REMs were performed by the lead investigator. At OUH 
recruitment of student helpers was necessary towards the end of the data collection. 
The student helpers were thoroughly trained and it was ensured that they understood 
and followed protocol. After receiving practical experience with performing the 
REMs during the follow-up visits, the initial protocol was revised due to an ineffective 
work procedures. The ineffective procedure consisted of the need to turn off and 
remove the HA from the patient and repeating the whole of Protocol 1 (Table 3.1). In 
this process, the risk of displacing the probe tube and introducing a measurement error 
arose. Additionally, the repetition of Protocol 1 prolonged measurement time and did 
not take advantage of the useful measurements from the first REM. The first protocol 
was used from March to June 2017, after which the second protocol was used for the 
remainder of the project. The update in Protocol 2 resulted in only having to repeat 
the last three measurements in case of a HA adjustment, as the REUG and 
REOR/REOG and calibration was stored from the initial REM (Table 3.1) 
Table 3.1 Real ear measurement protocols. When nothing else is stated, the International 
Speech Test Signal (ISTS) was used. Protocol 1 was used in from March to June 2017 before 
revision of the protocol. Protocol 2 was used for the rest of the data collection. For the long 
form of the abbreviations please see Table 3.2. 
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Real ear measurements (REMs) were the first task at the follow-up visits and was 
performed using the REM module (REM440) of Affinity 2.0 (Interacoustics) 
following the REM standards: IEC 61669, (2015); ISO 12124, (2001); ANSI/ASA 
S3.46, (2013). The loudspeaker faced the centre of the room and the patients were 
positioned 1 metre away, facing the loudspeaker. Calibration of probe tubes was 
performed with pink noise in Protocol 1 and with the International Speech Test Signal 
(ISTS) (Holube et al., 2010) in Protocol 2. Calibration removed the acoustic effects 
of the probe tube and microphone during the REM, making them ‘acoustically 
invisible’ (Pumford and Sinclair, 2001). Calibration was repeated before every REM. 
The calibrated probe tubes were inserted into the ear canal under visual guidance using 
an otoscopy to ensure that the tip of the probe tube was placed 2–5mm from the 
tympanic membrane. Having the probe tube closer than 2 mm can result in an adverse 
effect of standing waves. Correct placement of the probe tube provides accuracy 
within 2 dB of the true value at the eardrum up to 8 kHz, and prevents the appearance 
of insufficient high-frequency gain (Hawkins and Mueller, 1992). 
The first measurement made was REUG (Table 3.2), which evaluates the natural gain 
provided by the pinna and the ear canal at a 65 dB SPL using a pink noise/ISTS signal 
(Table 3.1).  
The second measurement made was the REOG/REOR. It was done using a 65 dB 
signal and with the HA inserted in the patients ear canal, but turned off. This is to 
determine the impact of the earplug on the external ear canal acoustics. The REOG is 
the difference in dB between the input signal and the signal measured at the tympanic 
membrane, whereas the REOR is the sound pressure level at the tympanic membrane 
for a given input signal.  
Table 3.2 Real ear measurement terminology. 
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In cases of an open fitted HA, the Stored Equalisation method (Hawkins and Mueller, 
1992) was used in order to accommodate for the amount of sound leaking out of the 
ear canal and onto the reference microphone (Figure 3.2). The calibration ensures that 
a constant signal intensity is maintained, so as to achieve the correct measurement 
level at the patient’s ear.   
 
 
The third measurement, the REIG or REAR/REAG, was taken with the HA inserted 
and turned on. The ISTS signal was used as input at three SPLs: 55; 65; and 80 dB 
SPL to test the gain provided by the HA in-situ. See Table 3.2 for an explanation of 
the abbreviations and calculations of the different measurements. 
3.5. HEARING AIDS 
Danish citizens with a serviceable HL are entitled to HA treatment. Treatment in a 
public clinic is free of change regardless of the type of HA fitted. The HAs offered in 
the public clinics are regulated by a tendering procedure, which is carried out by 
Foto A. Wolff 
Probe tube 
Probe 
microphone 
Reference 
microphone 
Hearing aid 
Figure 3.2 Illustration of the headset (IHM60) when mounted on a patient undergoing a real 
ear measurement. Hearing aid, probe tube, probe microphone and reference microphone as 
marked on the illustration (Photo: Wolff, A. 2018). 
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Amgros I/S on behalf of the five regions of Denmark. The HAs are categorised 
according to the type and complexity of HL. The overall categories (cat.) are cat. A/B 
(complex HL) and cat. C/D (less complex HL). 
Due to the participation of Oticon, GN Resound and Widex in the project and to obtain 
balanced representation of HAs, patients were primarily fitted with HAs from one of 
the three manufacturers. To ensure equal distribution of HA fitted, patients were 
randomised to either one of the three manufactures upon entry to the study. All 
companies selected one of their HAs to cover the HA treatment in cat. A/B and one 
to cover treatment in cat. C/D. The randomisation was undertaken through REDCap 
according to a simple randomisation key. If HAs from the assigned company were 
found unsuitable, for whatever reason, an alternative was found through the tender 
(Table 3.3). This agreement was approved by Amgros. 
Manufacture  Number of HA fitted (%) 
Oticon  575 (29) 
GN Resound  536 (27) 
Widex 497 (25) 
Other (Sivantos, Phonak, Rexton, Bernafon) 189 (10) 
Not registered   164 (8) 
 
Table 3.3 Distribution of HAs fitted, according to manufacturer.  
Our initial objective was to register details on HA usage with regard to sound 
environment, program use and average usage time. The HA manufacturers’ software 
displays different degrees of insight into the HA log data and this limited the level of 
detail we were able to register homogeneously across brands. Thus, the only common 
registration across manufacturers was the average use time of HA. 
3.6. HEARING AID FITTING 
The HA fitting was undertaken using a fitting strategy based on the individual HL 
measured with pure tone audiometry at the first visit. In the vast majority of fittings, 
the HAs were adjusted according to the proprietary fitting strategy developed and 
suggested by the HA manufacturer in question (97% of the patients completing 
follow-up). In some cases, fitting according to a standard fitting algorithm such as 
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NAL-NL1 or NAL-NL2 was done. Due to the variance of patient needs and 
acclimatisation effects, fitting procedures were completed by fine-tuning the HAs 
according to individual preferences. Acceptance of loud and high pitched noises was 
tested according to local tradition. In relevant cases, volume control, tele coil and 
streaming were activated and programs were created to fit individual needs. 
3.7. DATA MANAGEMENT 
The BEAR database was built using a browser-based electronic data capture system, 
REDCap (Harris et al., 2009) hosted at OPEN, Region of Southern Denmark. The 
database contains basic patient information alongside their direct survey entries. An 
administration instrument of REDCap was used to manage the patients’ appointments 
at the departments and distribute their survey links.  
The audiological data was stored locally in AuditBase 5 (AuditData, 2018). The 
integration framework, NOAH System 4 (HIMSA, 2018), was used to pass results 
from AuditBase on to the Affinity software needed for performing the REM. After 
data collection, the audiological and REM data was extracted from each of the 
software using the CPR numbers to identify the relevant patient records. Data from 
the software was merged with data from REDCap and stored using SharePoint hosted 
by OPEN, Southern Region of Denmark. 
The data analysis in the studies where performed using the statistical software STATA 
version 15 (Stata Corp.) and R (R Core Team, 2014). 
3.8. ETHICAL CONSIDERATIONS  
In accordance with Danish law, an application for ethical approval for the BEAR 
project (S-20162000-64) was sent to the Regional Committee on Health Research 
Ethics in the Region of Southern Denmark (RSD) and was not found notifiable by the 
committee. All studies in this thesis are part of the BEAR project, hence no further 
application of ethical approval was needed.  
As personal data was collected and stored, notification of the BEAR project (Journal 
number 16/18815) was send to the Danish Data Protection Agency via the RSD in 
accordance with the Data Protection Act and the General Data Protection Regulation 
(GDPR), and was approved. All participating partners in the BEAR project signed a 
Data Processing Agreement containing the applicable rights and obligations when 
handling personal data in this project. All studies in this dissertation comply with this 
Data Processing Agreement made between AAUH and RSD (Journal number 
18/15794). The signed agreement is filed using SharePoint at OPEN hosted by the 
RSD. 
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To ensure patients’ autonomy, written, informed consent was given by the patients 
upon entering the project. Written information was provided by sending an 
information letter by email (E-Boks) to all patients before data-collection. The 
researchers further provided verbal information to the participants when meeting them 
at the clinics. Patients were made aware of their right to withdraw their consent and 
participation at any time without justification.   
The patients were informed about confidentiality, which was obtained by the secure 
storage of their data. In the reporting of the data, it was ensured that individual patients 
could not be identified.  
Patients were treated in accordance with the ethical obligation (CIOMS, 2002) to treat 
each patient with what is right and proper and to secure equitable distribution of the 
burdens and benefits of participation in the project. The only limitation and threat 
against this obligation is the fact that patients with cognitive impairments or who are 
unable to read and understand Danish were excluded from participating in the project. 
The exclusion criterion was based on the questionnaire restrictions. The inequitable 
distribution is justified as it protects the patients’ rights when the patients is not 
capable of protecting their own interests, for example when giving informed consent.
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CHAPTER 4. AIM AND HYPOTHESIS 
The overall aim of the dissertation was to explore and describe health-related quality 
of life in patients with HL before and after treatment with HAs on the basis of the 
BEAR database.  
The specific objectives and hypothesis of each manuscript follows. 
4.1. MANUSCRIPT 1 
The first manuscript’s objective is to describe changes in HRQoL in new and 
experienced users after two months of HA treatment using their profile and total 15D 
score as a measure.  
The first hypothesis is that experienced HA users (before HA renewal) have a lower 
score of HRQoL than first-time HA users (before HA fitting) at baseline. The 
experienced user is expected to be older and to have a more severe HL than first-time 
HA users.   
The second hypothesis is that first-time HA users benefit more from HA treatment 
than experienced users after two months, when measured using 15D. This is because 
the first-time HA users are expected to have a smaller mean HL than the experienced 
users and it would therefore be easier to provide adequate alleviation. 
4.2. MANUSCRIPT 2 
The second paper’s objective is to describe changes in outcome measures in patients 
with asymmetrical HL compared to patients with symmetrical HL, and to discuss the 
different clinical references defining asymmetrical HL.  
The first hypothesis is that patients with asymmetrical HL experience lower benefits 
from HAs when measured with 15D and SSQ-12 before and after HA treatments 
compared to patients with symmetric HL.  
The second hypothesis is that the type or definition of asymmetric HL is predictive of 
the change in outcome measures after HA treatment. 
4.3. MANUSCRIPT 3 
The third paper’s objective is to describe the change in HRQoL when assessing HA 
fitting by REM measurements. The obtained real-ear aided response (REAR) is 
compared to a REAR-reference prescribed by the NAL-NL2. 
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The first hypothesis is that patients, who are fitted close to the NAL-NL2 reference 
obtain greater improvement in self-reported outcomes than patients fitted further from 
the NAL-NL2 reference.   
The second hypothesis is that experienced HA users need a HA fitting closer to the 
NAL-NL2 reference to achieve the greatest HRQoL improvement compared to first 
time users.
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CHAPTER 5. RESULTS AND 
DISCUSSION 
5.1. MANUSCRIPT 1  
The first manuscript of this dissertation investigates the HRQoL of first-time and 
experienced HA users, measured with the generic questionnaire 15D. The focus when 
including patients in AAUH was on first-time HA users, while the experience level of 
the patients was not applied as an inclusion criteria in Odense. The choice to include 
experienced users made it possible to investigate HRQoL in the period just before, 
and the benefit from, HA renewal. The general study population was stratified based 
on sex, severity of HL and average use time of HAs. The only group that did not 
significantly improve in self-reported outcome after HA treatment, as measured with 
the 15D, was the group of patients with severe to profound HL. This is consistent with 
previous findings, indicating that this group of patients have greater levels of anxiety 
and depression leading to a negative impact on general HRQoL (Carlsson et al., 2001). 
With difficulty of hearing and less benefit from the use of HAs, this group of patients 
have a higher risk of social isolation (Hawthorne, 2008) and lower HRQoL than their 
better hearing peers (Hawton et al., 2011). The total 15D score did not change for 
either of the two groups when assessed against the minimal importance change (MIC, 
0.015) of the 15D. Although, when tested the group of first-time users did significantly 
improve in score. 
The result regarding the 15D-3 showed that first-time users of HAs had higher (better) 
scores at baseline than did experienced HA users. When investigating the benefit after 
first fit/renewal of HAs, both groups showed a significantly improved 15D-3 score, 
although first-time users improved considerably more. The improvement found for 
the first-time users is consistent with the findings found by Niemensivu et al. (2015). 
The 15D-3 score was found to positively correlate with average daily use time of HAs 
and the patient’s motivation for improving their hearing by means of HAs. The 
association of HRQoL and average use time of HAs has previously been reported 
(Laplante-Lévesque et al., 2014). Likewise, the effect of motivation has been shown 
to have a positive impact on use time of HAs (Aazh, 2016). Additionally, 
improvement in sexual activity (15th question of the 15D) was found to be significant 
in both groups. A previous study (Bakır et al., 2013) found poorer sexual health in 
men with mild to moderate sensorineural HL. This result is supported in the study by 
Niemensivu et al., (2015) who also makes use of the 15D-3. 
 
46
 
5.2. MANUSCRIPT 2 
The second manuscript of the dissertation investigated the impact of having AHL for 
the outcomes measured using 15D-3 and the SSQ12 compared to patients with SHL. 
In the study population only four patients had UHL, and hence, the vast majority of 
cases with asymmetry had bilateral HL. As no universal standard definition of AHL 
exists, to describe clinically relevant AHL in terms of HA treatment three different 
definitions were applied to the study population: interlateral difference in 1) PTA >15 
dB HL, 2) WRS >15% and 3) audiogram configuration as classified by IEC 60118-
15. The three definitions identified different subpopulations with AHL, with only a 
small common overlap (n=159). The PTA definition identified the smallest subgroup. 
Regardless of the definition, patients characterised as having AHL had significantly 
lower mean 15D-3 score than their SHL peers. After adjusting for sex, age and better 
hearing ear PTA (BHE-PTA), the benefit of HAs continued to be significantly lower. 
This is consistent with previous research (Vannson et al., 2015) using the self-reported 
generic Glasgow Health Status Inventory (GHSI) (Gatehouse, 1999) and the SF-36 
(Parving et al., 2001).  
The results regarding SSQ12 showed significant negative impact of AHL on the 
spatial domain of SSQ at baseline, for all three definitions of AHL, whereas no 
difference was found regarding the benefit from HA treatment between patients with 
AHL and their SHL peers. This suggests that although spatial hearing improves in 
patients with AHL after HA treatment, it does not seem to fully compensate the offset 
from AHL. By means of logistic regressions, BHE-PTA’s contribution to the lower 
score in the spatial domain was assessed and was found to be an explanatory factor 
for the lower spatial score. No studies were found to assess the effect of SSQ12 in 
relation to AHL, though similar studies using UHL found that patients with UHL of 
similar severity of HL on the BHE as those with SHL, have compromised self-
assessed speech intelligibility and increased listening efforts (Giolas and Wark, 1967; 
Newman et al., 1997; Wie, Pripp and Tvete, 2010). 
There may not be enough substantiation from drawing conclusions regarding AHL 
from the results of studies on UHL, though one might nonetheless speculate that the 
two groups experience some of the same limitations due to their asymmetry. 
5.3. MANUSCRIPT 3 
The third manuscript in the dissertation further investigated HRQoL in relation to 
REM. The study population (N=693) is patients who had REM performed according 
to the second protocol. The REAR was compared to a reference prescribed by the 
NAL-NL2 based on the individual patient audiogram. Being on reference was defined 
as a difference between REAR and REAR-reference on +/-10 dB. Data on 6 
frequencies were obtained, 0.25, 0.5, 1, 2, 4 and 8 kHz. Plotting the average deviation 
from the NAL-NL2 reference, only nine patients were within +/- 10dB on all 6 
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frequencies on both ears. Restricting the number to the 4 center frequencies (0.5, 1, 2, 
and 4 kHz), 150 patients were within +/- 10dB on all four targets on both ears.  
Comparing the score of the 15D, 15D-3, SSQ-12 and the individual SSQ domains 
between the patients on reference (n=150) with the patients not on reference, no 
difference were found between the groups. 
The aspects of further identification of low benefit groups in terms of 15D and SSQ-
12 and characterisation of their REM profiles is limited by the current study material 
of 693 patients, because subgroups are likely to be too small. Future analysis awaits 
the inclusion of additional REM data up to 1,500 cases, where the strength of 
statistical analyses can be substantially improved. 
At time of submission the manuscript needs finishing internal review and therefore 
has a status of being in preparation.  
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CHAPTER 6. CONCLUSIONS AND 
PERSPECTIVES 
The main aim of this dissertation is to investigate the group of patients referred to 
audiological departments for HAs and their self-reported HRQoL in relation to 
treatment. We hypothesised that different patient characteristics had an impact on the 
self-reported benefit of HA. The focus on the low-benefit groups was simply to gain 
knowledge of these groups in order to focus future investigations in their favour.  
In the case of the experienced users’ reporting an improved hearing-related quality of 
life after HA renewal, one could speculate whether their previous HAs were optimally 
fitted, which would account for the improvement after fitting optimisation. In the 
present work, it was not established where and when a potential decline in HL 
occurred prior to the renewal fitting, and whether this could have been compensated 
with re-fitting rather than HA renewal. Longer follow-up periods to assess the 
development of HRQoL over time is required. Some of the longest follow-up periods 
do not exceed one year. 
Results from the second paper sheds new light on a group of patients who might 
benefit from a tailored approach to fitting, considering the specifics of the AHL. The 
difficulties encountered and consequences experienced regarding HRQoL when 
having AHL is known, but limited treatments for the offset of the asymmetry exist. In 
current clinical practice, if a patient is found to have an AHL upon first hearing 
assessment, further examinations are scheduled to rule out retrocochlear diseases. In 
the case of a normal follow-up examination, whether that be an auditory brainstem 
response (ABR) or a MRI-scanning, the conclusion is no sign of disease. The patient 
is often given the result and no further treatment or counselling is initiated. Future 
research is needed to explore possible ways of improving HRQoL in this group of 
patients. In a 2009 study (Saunders, Lewis and Forsline, 2009) which investigated the 
effect of prefitting counselling on HA outcomes, researchers showed a small but 
significant effect on matching expectations. They also found that positive expectations 
results in greater improved outcome. One could speculate whether advanced HA 
technology could be adapted to effectively compensate for the asymmetry component 
of AHL or perhaps additional counselling could be the option.  
The results from the third manuscript showed that the HA fitting performed at the 
departments were very close the targets prescribed by the NAL-NL2 for the 0.25-1 
kHz pure tone frequencies. The HAs were on average fitted above the reference 
prescribed by NAL-NL2. In contrast, the frequencies 4 and 8 kHz were showing the 
largest average deviation from the reference, both fitted under reference (less gain 
than prescribed by the NAL-NL2). Comparing the patients defined as being on 
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reference with the ones then defined as not being on reference showed no difference 
between groups when assessed on HRQoL (15D), hearing related QoL (15D-3) and 
hearing handicap (SSQ12). 96% of the patients were fitted with proprietary 
prescription which has been shown in the literature not to provide sufficient gain when 
compared to the prescribed gain by standard fitting algorithms (Keidser, Brew and 
Peck, 2003; Aarts and Caffee, 2005; Mueller, 2005). Whether REM verification of 
HA output should be considered a permanent part of the HA fitting procedure has not 
been investigated in this study. However, given the current awareness of health 
economics it may seem reasonable to question whether more investigation are needed 
before REM is considered as a part of routine.    
The increase in general healthcare costs has facilitated the growing interest in 
objectifying the benefits gained from the money spent. In short, is the money worth 
the treatment? In order to make this evaluation, the need for comparison across the 
medical fields is needed. To this end, several generic questionnaires have been 
developed, but the task of creating a questionnaire sensitive to a very large number of 
diseases while still being feasible for patients to answer remains unsolved. The utility 
value associated with the QoL-questionnaires, in order to calculate QALYs, is based 
on answers from large evaluation surveys of the general population. This poses 
another potential challenge, as the general population is being asked to evaluate 
dimensions which they might never have experienced (Brazier et al., 2018). Despite 
the challenges, the use of generic HRQoL questionnaires and calculations of QALYs 
is a valuable tool when prioritising resources. In October 2019 the Danish Medicines 
Council announced that the use of QALYs is being discussed for use in their further 
work (Poulsen, 2019). The intention for the use of QALYs is that it will provide a 
uniform basis for the evaluation of treatment decisions and contribute to transparency 
in public managements of resources according to given political strategies. 
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